Reliance Life gets regulatory nod for trials of 2-dose vaccine

The drug regulatory authority on Thursday approved Reliance Life Sciences, part of India’s largest private sector enterprise-application, seeking to conduct clinical trials of its recombinant protein-based Covid-19 vaccine candidate.